APA (7th ed.) Citation

T, Z., J, L., P, D., Z, L., Z, H., Z, Z., . . . J, M. (2026). FDX1 as a predictive biomarker and therapeutic target for lymph node metastasis in gastric cancer. Clinical and experimental medicine, 26(1), . https://doi.org/10.1007/s10238-026-02160-0

Chicago Style (17th ed.) Citation

T, Zhang, et al. "FDX1 as a Predictive Biomarker and Therapeutic Target for Lymph Node Metastasis in Gastric Cancer." Clinical and Experimental Medicine 26, no. 1 (2026). https://doi.org/10.1007/s10238-026-02160-0.

MLA (9th ed.) Citation

T, Zhang, et al. "FDX1 as a Predictive Biomarker and Therapeutic Target for Lymph Node Metastasis in Gastric Cancer." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10238-026-02160-0.